Results 101 to 110 of about 7,977 (217)

Plasma Leptin Levels Before and After Bromocriptine Treatment in Female Patients with Prolactinoma

Endocrinology Research and Practice, 2022
Both It is known that increased body weight is associated with prolactinomas. However, effects of bromocriptine treatment on plasma leptin levels is not clear yet.
Metin Özata, Bekir Çakır, Serdar Güler   +2 more
doaj  

Diethylstilbestrol-induced prolactinoma: dose-related tumor growth and effect of catecholaminergic cells on prolactin tumor cells

, 2005
Background: Prolactinoma is a pituitary adenoma originating from prolactin-secreting epithelial cells of the adenohypophysis. Unfortunately, there appears to be a relatively high recurrence rate despite all pharmacological, radiological, and surgical ...
Palaoglu, S, Ruacan, S, Sungur, A, Ozdemir, N, Cila, A   +4 more
core   +1 more source

Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma

Scientific Reports
Leflunomide’s anti-tumor effects have been investigated in various types of tumors; however, its impact on pituitary adenoma, particularly prolactinoma, is unclear.
Xiangdong Pei, Yuyang Peng, Huachun Yin, Zhenle Zang, Kaifeng Shen, Song Li, Chunqing Zhang   +6 more
doaj   +1 more source

Mean platelet volume in patients with prolactinoma

, 2016
Objective Prolactin is a multifunctional pituitary hormone. The effect of prolactin on platelet activation is not well understood. Prolactinomas are the most common type of pituitary adenomas, and they are medically responsive to dopamine agonists. Mean
Reyhan Ersoy (6129737), Hüsniye Başer (6132044), Bekir Çakır (6132047), Abbas Ali Tam (6132038), Cafer Kaya (6132041)   +4 more
core   +1 more source

Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study

, 2011
Atherothrombosis is a multifactorial process, governed by an interaction between the vessel wall, hemodynamic factors and systemic atherothrombotic risk factors.
Suzanne Battjes, Danka J. F. Stuijver, Marcel Th. B. Twickler, Rogier van Zijderveld, Meijers, Joost C. M., Erik S. Stroes, Twickler, Marcel Th B., Schlingemann, Reinier O., Bisschop, Peter H., Reinier O. Schlingemann, Battjes, Suzanne, Twickler, Marcel, Joost C. M. Meijers, Sondermeijer, Brigitte M., Stuijver, Danka J. F., van Zijderveld, Rogier, Peter H. Bisschop, Stuijver, Danka J.F., Meijers, Joost C.M., Anne Q. Reuwer, Brigitte M. Sondermeijer, Stroes, Erik S., Reuwer, Anne Q.   +22 more
core   +1 more source

A case of rapidly increasing cabergoline-resistant male prolactinoma

Interdisciplinary Neurosurgery
Cabergoline, a dopamine agonist, is the first-line drug for treating prolactinoma. However, some rare cases exhibit resistance to cabergoline. Here, we report a rare case of prolactinoma in a male patient that recurred in a short period while the patient
Toshiya Ichinose, Yasuo Sasagawa, Mitsutoshi Nakada   +2 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Absence of an opioid stimulatory tone on Growth Hormone secretion in women with prolactinoma

, 2008
INTRODUCTION: Literature data suggest that prolactinoma is a tumor with a complex pathogenesis and that its growth is the result of changes at the pituitary and/or hypothalamic level.
FANCIULLI, Giuseppe, TOMASI, Paolo, DELITALA, Giuseppe   +2 more
core   +1 more source

High-Risk Prostate Cancer in a Patient with Untreated Prolactinoma and Castrate-Level Testosterone Suppression: A Case Report

Case Reports in Oncology
Introduction: Prolactinomas can induce castrate-level testosterone suppression by dysregulating the hypothalamic-pituitary-gonadal axis. While hypogonadism typically confers a reduced risk for prostate cancer (PCa), malignancy can still occur ...
Tara A. Seibert, Afreen Shariff, Hannah D. McManus   +2 more
doaj   +1 more source

Natural and molecular history of prolactinoma: insights from a Prlr-/- mouse model

, 2017
International audienceLactotroph adenoma, also called prolactinoma, is the most common pituitary tumor but little is known about its pathogenesis. Mouse models of prolactinoma can be useful to better understand molecular mechanisms involved in abnormal ...
Young, Jacques, Reiner A. Veitia, Martin, Agnès O, Binart, Nadine, Chiara Villa, Aurélie Auguste, Bernard, Valérie, Anne Guillou, Caburet, Sandrine, Sandrine Caburet, Veitia, Reiner A., Villa, Chiara, Duvoid-Guillou, Anne, Auguste, Aurelie, Valérie Bernard, Agnès Martin, Sophie Lamothe, Lamothe, Sophie, Nadine Binart, Jacques Young   +19 more
core   +1 more source